What is Acadia Healthcare's revenue?

Acadia Healthcare (ACHC) generated $3.4B in revenue over the trailing twelve months, up 6.8% year over year.

Is Acadia Healthcare profitable?

Acadia Healthcare is not currently profitable: it reported a net loss of $1.1B over the trailing twelve months, a -32.8% net margin.

What is Acadia Healthcare's earnings per share?

Acadia Healthcare's diluted EPS over the trailing twelve months is $-12.20.

Where does Acadia Healthcare's income statement data come from?

Every line is extracted from Acadia Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Acadia Healthcare ACHC Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Net interest income	-$38.33M-31.3%	-$37.93M-26.1%	-$36.62M-22.4%	-$35.14M-20.5%	-$29.18M-7.2%
Total revenue	$828.8M+7.6%	$821.46M+6.1%	$851.57M+4.4%	$869.23M+9.2%	$770.51M+0.3%
Compensation and benefits	$467.04M+4.9%	$460.85M+8.3%	$462.17M+7.9%	$452.42M+7.8%	$445.27M+6.6%
Occupancy and equipment	$11.73M+0.7%	$12.02M+2.6%	$11.74M-5.3%	$12.61M+6.1%	$11.66M-1.7%
Professional fees	$53.2M+16.4%	$48.33M+1.8%	$51.48M+6.1%	$49.96M+4.0%	$45.71M0.0%
Depreciation and amortization	$52.43M+11.5%	$45.75M+15.7%	$47.47M+26.1%	$49M+35.8%	$47.03M+29.4%
Goodwill impairment	——	$249.05M—	$249.05M—	$249.05M—	$249.05M—
Acquisition and integration costs	$22.01M-29.2%	$25.21M-14.7%	$42.92M+420%	$64.43M+958%	$31.07M+991%
Other operating expenses	$131.08M+15.0%	$176.11M+49.4%	$128.79M+14.8%	$134.41M+22.5%	$114M+12.8%
Total costs & expenses	$817.84M+8.0%	$1.99B+170%	$811.59M+13.2%	$819.23M+18.8%	$757.04M+13.1%
Other income (expense), net	-$401K-449%	——	-$779K-1,793%	-$1.06M—	-$73K-102%
Gain (loss) on extinguishment of debt	——	——	——	——	-$1.27M—
Gain (loss) on disposal of assets	$1.22M—	——	——	$8.72M—	——
Income before income taxes	$10.96M-18.6%	-$1.17B-3,177%	$39.99M-59.4%	$50M-53.0%	$13.47M-86.4%
Income tax expense	$6.5M+47.6%	$7.84M+75.1%	$1.67M-93.9%	$12.07M-52.9%	$4.4M-78.1%
Net income	$4.11M-51.0%	-$1.18B-3,710%	$36.25M-46.8%	$30.13M-61.6%	$8.37M-89.0%
Net margin	0.5%-0.6pp	-143.3%-148pp	4.3%-4.1pp	3.5%-6.4pp	1.1%-8.9pp
Net income attributable to noncontrolling interests	$359K-48.0%	——	$2.07M-36.0%	$7.81M+234%	$690K-71.1%
Diluted earnings per share	$0.05-44.4%	-$12.98-3,706%	$0.40-45.9%	$0.33-61.2%	$0.09-89.2%
Basic earnings per share	$0.05-44.4%	-$12.98-3,809%	$0.40-45.9%	$0.33-61.6%	$0.09-89.3%
Weighted-average shares, diluted	90.9M-1.3%	90.7M-1.5%	90.6M-1.7%	90.4M-1.7%	92M0.0%
Weighted-average shares, basic	90.5M-1.2%	90.7M-1.0%	90.4M-1.4%	90.3M-1.4%	91.7M+0.3%
Adjustments To Additional Paid In Capital Other	——	——	$262K-26.6%	$692K—	——
Share-based compensation expense related to employee stock plans	$7.96M-8.3%	$6.45M-36.1%	$6.03M-36.3%	$10.55M+18.9%	$8.68M0.0%
Amortization Of Financing Costs	$1.25M+18.7%	$1.35M+31.5%	$1.24M+20.3%	$1.22M+20.0%	$1.06M+3.9%
Business Exit Costs1	$4.96M+129%	——	$3.21M+347%	$10.07M+610%	$2.17M+164%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$25.23M+69.0%	——	——	$40.19M+29,648%	$14.93M+166%
Contract With Customer Liability Revenue Unrecognized	——	——	——	——	$14.3M+389%
Deferred taxes	$10.34M+284%	——	$12.06M-29.5%	-$3.13M-115%	-$5.62M-132%
Effective tax rates	$0.59+81.3%	——	$0.04-84.8%	$0.240.0%	$0.33+61.1%
Fair Value Of Assets Acquired	$17.29M-12.5%	$16.93M—	$16.83M+373%	$113K-69.4%	$19.77M-64.3%
Gain/(loss) on dispositions, net	$1.22M—	——	——	$8.72M—	——
Goodwill Additions	$5.07M-40.7%	$19.27M—	——	——	$8.56M-75.6%
Goodwill impairment losses	——	$249.05M—	$249.05M—	$249.05M—	$249.05M—
Government Investigations	$12.42M-59.9%	——	$38.74M+1,149%	$53.53M+2,510%	$31.01M+6,347%
Accounts payable and other current liabilities	$24.4M+364%	——	$5.9M+211%	$36.93M—	-$9.24M+97.7%
Increase (Decrease) in Accounts Receivable	$31.15M+0.5%	$10.07M—	$22.3M—	$11.67M+266%	$30.99M+35.2%
Accrued compensation and employee benefits	-$34.57M-74.6%	$21.52M+54.2%	$9.1M—	$15.86M—	-$19.8M+20.9%
Increase (Decrease) in Other Current Assets	-$27.5M-405%	$29.62M+618%	$13.79M—	——	$9.02M-42.3%
Increase (decrease) in other current liabilities	$270K-98.4%	$70.74M+1,932%	——	$4.27M+39.7%	$16.69M+147%
Increase (decrease) in other assets	$542K-55.4%	$426K—	$3.18M—	$6.47M+4,532%	$1.21M+274%
Interest Income (Expense), Operating	-$38.33M-31.3%	-$37.93M-26.1%	-$36.62M-22.4%	-$35.14M-20.5%	-$29.18M-7.2%
Legal Accounting And Other Acquisition Related Costs	$716K+134%	——	$976K-66.8%	$825K-59.4%	-$2.11M-144%
Settlement amount awarded	——	——	——	——	——
Management Transition Costs	$3.91M—	——	$0-100%	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$23.91M-87.2%	$193.28M+139%	$43.82M+25.6%	$57.46M—	$186.69M-61.4%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$60.21M+67.1%	-$92.44M+54.5%	-$129.76M+32.8%	-$150.78M+3.0%	-$183.24M+0.7%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$61.53M+436%	——	$73.21M-55.1%	$133.5M-22.0%	$11.48M+104%
Net Income Loss Attributable To Noncontrolling Interest	$359K-48.0%	——	$2.07M-36.0%	$7.81M+234%	$690K-71.1%
Net Income Loss Attributable To Redeemable Noncontrolling Interest	$359K-48.0%	$279K—	$2.07M—	$7.81M+234%	$690K-71.1%
Number Of Facilities	275+1.9%	——	4—	4—	270+4.7%
Number Of Facilities Operated By Non Wholly Owned Subsidiaries	17+41.7%	——	3—	——	12+20.0%
Number of reportable segments	10.0%	——	——	——	1—
Occupancy and Related Charges	$11.73M+0.7%	$12.02M+2.6%	$11.74M-5.3%	$12.61M+6.1%	$11.66M-1.7%
Other Noncash Income (Expense)	-$401K-449%	——	-$779K-1,793%	-$1.06M—	-$73K-102%
Payment for (Proceeds from) Other Investing Activity	$30K-46.4%	——	$44K+2,100%	$45K-97.8%	$56K-93.8%
Payments for Repurchase of Common Stock	——	——	——	$3.15M—	$46.88M—
Payments of Debt Issuance Costs	——	——	——	——	$18.62M+1,126%
Payments Of Distributions To Affiliates	——	——	$1.89M+28.2%	——	——
Payments Of Dividends Minority Interest	——	——	$1.89M—	——	——
Payments to Acquire Businesses, Net of Cash Acquired	——	——	——	——	$8.59M-82.9%
Payments to Acquire Property, Plant, and Equipment	$76.56M-56.2%	$93.19M-54.2%	$136.24M-28.4%	$167.75M+8.8%	$174.63M+22.6%
Proceeds From Contributions From Affiliates	$743K—	$3.64M+117%	——	——	——
Dividends received from unconsolidated affiliates	$18.03M+23.4%	$21.68M—	$23.91M—	$7.3M+959%	$14.61M+541%
Debt issued (Note 13)	——	——	——	——	$1.2B+243%
Financing — other	-$26K-23.8%	-$23K—	$0-100%	-$49K—	-$21K+94.1%
Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises	-$2.74M-41.7%	——	-$237K—	-$1.78M-172%	-$1.94M-91.1%
Dispositions of property, plant, and equipment	$16.38M+38,000%	$697K+235%	$6.53M+36,167%	$16.58M+1,338%	$43K-99.5%
Redeemable Noncontrolling Interest Resulting From An Acquisition	$17.29M+59.0%	$17.23M—	$16.48M—	$0—	$10.87M—
Repayments of Long-term Lines of Credit	$55M-94.7%	——	——	——	$1.04B+6,800%
Repayments of Secured Debt	$4.06M—	——	$4.06M-73.6%	——	——
Payments on debt	——	——	——	——	$670.86M—
Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises	-$2.74M-41.7%	-$273K+49.3%	-$237K+69.0%	-$1.78M+16.5%	-$1.94M+62.2%
Revenue From Contract With Customer Excluding Assessed Tax	$828.8M+7.6%	$821.46M+6.1%	$851.57M+4.4%	$869.23M+9.2%	$770.51M+0.3%
Stock-based compensation	$7.96M-8.3%	$6.45M-36.1%	$6.03M-36.3%	$10.55M+18.9%	$8.68M0.0%
Granted (in shares)	1.1M—	——	——	——	0-100%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period	24.4K-38.0%	185.6K+114%	——	——	39.3K+71.9%
Forfeited or expired (in shares)	$61.91+7.7%	$55.00-17.8%	——	——	$57.51-8.4%
Granted (in shares)	$11.68—	——	——	——	——
Value of shares repurchased	——	-$4K—	-$9K—	$3.16M—	$47.27M—
Supplies Expense	$29.49M+4.1%	$30.76M+7.7%	$30.41M+2.7%	$28.53M+2.3%	$28.34M+6.3%
Unrecognized tax benefit, penalty expense (benefit)	$46.9M-43.9%	——	——	——	$83.6M-4.9%
Add: dilutive effect of potential common shares (in shares)	$329K-14.3%	——	$170K-63.7%	$107K-74.2%	$384K-40.6%
EBITDA	$63.39M+4.8%	-$1.12B-1,549%	$87.45M-35.8%	$99M-30.5%	$60.5M-55.2%
EBITDA margin	7.6%-0.2pp	-136.8%-147pp	10.3%-6.4pp	11.4%-6.5pp	7.9%-9.7pp
EBIT	$10.96M-18.6%	-$1.17B-3,177%	$39.99M-59.4%	$50M-53.0%	$13.47M-86.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Acadia Healthcare.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Healthcare's revenue?: Acadia Healthcare (ACHC) generated $3.4B in revenue over the trailing twelve months, up 6.8% year over year.
Is Acadia Healthcare profitable?: Acadia Healthcare is not currently profitable: it reported a net loss of $1.1B over the trailing twelve months, a -32.8% net margin.
What is Acadia Healthcare's earnings per share?: Acadia Healthcare's diluted EPS over the trailing twelve months is $-12.20.
Where does Acadia Healthcare's income statement data come from?: Every line is extracted from Acadia Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.